CIK: 1794629 - Address: C/O Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell, WA 98011
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/2/25 16:33
6/30/25
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagSan Martin JavierWAOCHIEF MEM.d00.0004718772D
7/2/25 16:33
7/1/25
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagSan Martin JavierWAOCHIEF MES.d-30.29350-11-1372D
1/3/25 17:05
12/31/24
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagSan Martin JavierWAOCHIEF MEM.d00.0004736D
1/3/25 17:05
1/2/25
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagSan Martin JavierWAOCHIEF MES.d-60.56190-11-2336D
1/8/24 17:16
1/5/24
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSan Martin JavierCAOChief MeS-29335.260-8-4198D
11/22/23 14:31
11/20/23
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSan Martin JavierCAOChief MeS-56728.800-20-13132D
11/22/22 18:05
11/21/22
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSan Martin JavierCAOChief MeS-58529.990-20-1892D
11/22/21 16:56
11/19/21
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSan Martin JavierCAOChief MeS-1,35269.310-20-15111D
11/20/20 18:03
11/19/20
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSan Martin JavierCAOChief MeS-1,35369.390-20-13131D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact